HOLLY SPRINGS, NORTH CAROLINA
Advancing innovation on the East Coast
Behind the Scenes
OUR holly springs FACILITY
Our 700,000 sq. ft. manufacturing facility in Holly Springs, North Carolina will support our pharma division’s next-generation metabolic medicines portfolio, including treatments for obesity, ultimately helping to deliver life-changing science to patients.
This state-of-the art facility represents a $700+ million investment in the United States with potential expansion in the future. Stay in touch as construction continues!
This state-of-the art facility represents a $700+ million investment in the United States with potential expansion in the future. Stay in touch as construction continues!
WORK IN PROGRESS
Take a look at our latest site milestones!
Set to be operational by 2029, our expanded $2 billion plant will leverage advanced automation and digital tools to boost efficiency and sustainability while significantly expanding Genentech’s U.S.-based supply chain.
Set to be operational by 2029, our expanded $2 billion plant will leverage advanced automation and digital tools to boost efficiency and sustainability while significantly expanding Genentech’s U.S.-based supply chain.
OUR NEW SITE UNDER 30 SECONDS
We’re excited to share a look at our new Holly Springs site as we expand our manufacturing footprint and invest in the future of innovation.
Our new facility near Raleigh, North Carolina, an established biopharmaceutical talent hub, will serve as an important new setting within our manufacturing network to help deliver on the promise of our company’s life-changing science and industry-leading pipeline. We are thrilled to establish this relationship with the city of Holly Springs, where we expect to have a positive impact on the local economy and community, as we have across the United States since we pioneered the biotech industry nearly 50 years ago.
Ashley Magargee
Genentech CEO
This is a once-in-a-career opportunity to build a plant, and establish a team culture from scratch! You will join a team of change-makers, and innovators solving for the high-volume, medicine manufacturing needs of tomorrow.
Joash Mudalige
Site Head, Holly Springs
Genentech
Genentech
Standing up a plant from scratch isn't easy. You leave old habits behind and make sure every detail is right the first time, knowing it's all in service of CVRM patients. The best part? You get to be part of this facility's very first milestone.
Kartik Joshi
Principal Quality Assurance Specialist, Holly Springs
Genentech
Genentech
Every decision we make regarding process controls, quality, and efficient manufacturing ensures our therapies reach patients safely and on time. Knowing our attention to detail directly supports life-changing treatments gives a profound sense of purpose to our work.
Sarra Hassan
Senior Quality Assurance Specialist, Holly Springs
Genentech
Genentech
Leading a team that is building a state-of-the-art logistics operation while fostering an inclusive, high trust culture is the highlight of my professional journey and I hope to make it theirs as well.
Erin Hill
Head of Materials Management, Holly Springs
Genentech
Genentech
50 years of breakthroughs
The Impossible Bet chronicles Genentech’s 50-year journey from a bold napkin sketch into a biotechnology pioneer, showcasing how daring scientific innovation continues to transform patient lives and shape the future of care.
Evolution of manufacturing
Delivering new medicines demands innovation in medical discovery, and how those medicines are made. We are continually evolving the processes that move life-changing therapies from the lab bench to the patient.
Digging deeper into Obesity
Join co-host Maria Wilson and Genentech’s Manu Chakravarthy as they dive into the evolving science of obesity, exploring how evolutionary biology, shifting paradigms around stigma, and innovative new treatments are redefining long-term weight management.
